The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outpatient treatment with lisocabtagene maraleucel (liso-cel) across a variety of clinical sites from three ongoing clinical studies in relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
 
Carlos R. Bachier
Employment - HCA Healthcare
Consulting or Advisory Role - crispr therapeutics (Inst); Kadmon (Inst); Viracyte (Inst); WUGEN, Inc. (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
 
John E. Godwin
Speakers' Bureau - Abbvie; Bristol-Myers Squibb
 
Charalambos Andreadis
Employment - Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Celgene; Genentech/Roche; Gilead Sciences; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis
Research Funding - Amgen; Celgene; Cellerant; GlaxoSmithKline; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis
Travel, Accommodations, Expenses - Bayer; Celgene; Genentech; Gilead Sciences; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis
 
Maria Lia Palomba
Stock and Other Ownership Interests - Seres Therapeutics (I)
Honoraria - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Merck; Merck (I); Novartis (I); Pharmacyclics; Seres Therapeutics (I); Therakos (I)
Consulting or Advisory Role - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Kite, a Gilead company; Merck; Merck (I); Novartis; Novartis (I); Seres Therapeutics (I); Therakos (I)
Research Funding - Seres Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Intellectual Property Rights (I); Juno intellectual property rights (Inst)
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Alimera Sciences; Alimera Sciences; Bayer; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; MorphoSys; Novartis; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); Seagen (Inst)
 
Alison R. Sehgal
Research Funding - Juno Therapeutics; Kite/Gilead; Merck
 
Gerhard Hildebrandt
Stock and Other Ownership Interests - Abbvie; Aetna; Aimmune; ANGI Homeservices; Axim Biotechnologies; Bayer; Bayer; Bluebird Bio; Bristol-Myers Squibb/Medarex; Cardinal Health; CareTrust Reit; Celgene; Cellectis; Charlotte's Web; Clovis Oncology; crispr therapeutics; CVS Health; Endocyte; GW Pharmaceuticals; IDEXX Laboratories; Immunomedics; Insys Therapeutics; Johnson & Johnson; Juno Therapeutics; Kite, a Gilead company; Medical Properties Trust; Novartis; Pfizer; Procter & Gamble; Sangamo Bioscience; Scotts Miracle-Gro; Vertex
Consulting or Advisory Role - Incyte; Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer
Research Funding - Jazz Pharmaceuticals; Pharmacyclics; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Falk Foundation; Incyte; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer
 
Don A. Stevens
Consulting or Advisory Role - Amgen; Astellas Pharma; MorphoSys
 
Daanish Hoda
Stock and Other Ownership Interests - Aprea Therapeutics; Forty Seven
 
Edward J. Licitra
No Relationships to Disclose
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics
 
Thalia Andrea Farazi
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ana Kostic
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; Seagen
 
Nikolaus S. Trede
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lei Wang
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James Lymp
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David G. Maloney
Consulting or Advisory Role - Celgene; Eureka Therapeutics; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.